{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:40:42Z","timestamp":1762522842646,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-023-10331-4","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T12:02:41Z","timestamp":1689249761000},"page":"1315-1323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel opportunity to improve heart failure care: focusing on subcutaneous furosemide"],"prefix":"10.1007","volume":"28","author":[{"given":"Wahab J.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Arriola-Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda S.","family":"Mutschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bensimhon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Halmosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalman","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-6299","authenticated-orcid":false,"given":"Tamas","family":"Alexy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"10331_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N et al (2021) Universal definition and classification of heart failure. J Card Fail 27:387\u2013413. https:\/\/doi.org\/10.1016\/j.cardfail.2021.01.022","journal-title":"J Card Fail"},{"key":"10331_CR2","doi-asserted-by":"publisher","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R et al (2017) Heart Disease and Stroke Statistics Update: a report from the American Heart Association. Circ 135. https:\/\/doi.org\/10.1161\/CIR.0000000000000485","DOI":"10.1161\/CIR.0000000000000485"},{"key":"10331_CR3","doi-asserted-by":"publisher","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS et al (2022) Heart Disease and Stroke Statistics Update: a report from the American Heart Association. Circ 145. https:\/\/doi.org\/10.1161\/CIR.0000000000001052","DOI":"10.1161\/CIR.0000000000001052"},{"key":"10331_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/CEOR.S400882","volume":"15","author":"MD Zilberberg","year":"2023","unstructured":"Zilberberg MD, Nathanson BH, Sulham K, Mohr JF, Goodwin MM, Shorr AF (2023) Descriptive epidemiology and outcomes of patients with short stay hospitalizations for the treatment of congestive heart failure in the US. Clin Outcomes Res 15:139\u2013149. https:\/\/doi.org\/10.2147\/CEOR.S400882","journal-title":"Clin Outcomes Res"},{"key":"10331_CR5","doi-asserted-by":"publisher","unstructured":"Khan MS, Sreenivasan J, Lateef N, Abougergi MS, Greene SJ, Ahmad T et al (2021) Trends in 30- and 90-day readmission rates for heart failure. Circ Heart Fail 14. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008335","DOI":"10.1161\/CIRCHEARTFAILURE.121.008335"},{"key":"10331_CR6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","volume":"38","author":"M Urbich","year":"2020","unstructured":"Urbich M, Globe G, Pantiri K, Heisen M, Bennison C, Wirtz HS et al (2020) A systematic review of medical costs associated with heart failure in the USA (2014\u20132020). Pharmacoeconomics 38:1219\u20131236. https:\/\/doi.org\/10.1007\/s40273-020-00952-0","journal-title":"Pharmacoeconomics"},{"key":"10331_CR7","doi-asserted-by":"publisher","first-page":"e1932","DOI":"10.7205\/MILMED-D-17-00017","volume":"182","author":"AH Lin","year":"2017","unstructured":"Lin AH, Chin JC, Sicignano NM, Evans AM (2017) Repeat Hospitalizations Predict Mortality in Patients With Heart Failure. Mil Med 182:e1932\u2013e1937. https:\/\/doi.org\/10.7205\/MILMED-D-17-00017","journal-title":"Mil Med"},{"key":"10331_CR8","doi-asserted-by":"publisher","first-page":"162.e1","DOI":"10.1016\/j.amjmed.2008.08.026","volume":"122","author":"DS Lee","year":"2009","unstructured":"Lee DS, Austin PC, Stukel TA, Alter DA, Chong A, Parker JD et al (2009) \u201cDose-dependent\u201d impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med 122:162.e1-162.e9. https:\/\/doi.org\/10.1016\/j.amjmed.2008.08.026","journal-title":"Am J Med"},{"key":"10331_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ahj.2007.01.041","volume":"154","author":"S Setoguchi","year":"2007","unstructured":"Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154:260\u2013266. https:\/\/doi.org\/10.1016\/j.ahj.2007.01.041","journal-title":"Am Heart J"},{"key":"10331_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jchf.2013.12.003","volume":"2","author":"EF Lewis","year":"2014","unstructured":"Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ et al (2014) Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction. JACC Heart Fail 2:159\u2013165. https:\/\/doi.org\/10.1016\/j.jchf.2013.12.003","journal-title":"JACC Heart Fail"},{"key":"10331_CR11","doi-asserted-by":"publisher","unstructured":"Albuquerque de Almeida F, Al MJ, Koymans R, Riistama J, Pauws S, Severens JL (2020) Impact of hospitalisation on health-related quality of life in patients with chronic heart failure. Health Qual Life Outcomes 18:262. https:\/\/doi.org\/10.1186\/s12955-020-01508-8","DOI":"10.1186\/s12955-020-01508-8"},{"key":"10331_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0269216313477179","volume":"27","author":"K Whittingham","year":"2013","unstructured":"Whittingham K, Barnes S, Gardiner C (2013) Tools to measure quality of life and carer burden in informal carers of heart failure patients: a narrative review. Palliat Med 27:596\u2013607. https:\/\/doi.org\/10.1177\/0269216313477179","journal-title":"Palliat Med"},{"key":"10331_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/0269216313488812","volume":"27","author":"FA Malik","year":"2013","unstructured":"Malik FA, Gysels M, Higginson IJ (2013) Living with breathlessness: a survey of caregivers of breathless patients with lung cancer or heart failure. Palliat Med 27:647\u2013656. https:\/\/doi.org\/10.1177\/0269216313488812","journal-title":"Palliat Med"},{"key":"10331_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4330\/wjc.v14.i9.473","volume":"14","author":"AK Jha","year":"2022","unstructured":"Jha AK, Ojha CP, Krishnan AM, Paul TK (2022) 30-day readmission in patients with heart failure with preserved ejection fraction: insights from the nationwide readmission database. World J Cardiol 14:473\u2013482. https:\/\/doi.org\/10.4330\/wjc.v14.i9.473","journal-title":"World J Cardiol"},{"key":"10331_CR15","doi-asserted-by":"publisher","unstructured":"Giles L, Freeman C, Field P, S\u00f6rstadius E, Kartman B (2020) Humanistic burden and economic impact of heart failure \u2013 a systematic review of the literature. F1000Res 8:859. https:\/\/doi.org\/10.12688\/f1000research.19365.2","DOI":"10.12688\/f1000research.19365.2"},{"key":"10331_CR16","doi-asserted-by":"publisher","unstructured":"Harjola V-P, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca H-P, Chioncel O et al (2017) Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 19:821\u201336. https:\/\/doi.org\/10.1002\/ejhf.872","DOI":"10.1002\/ejhf.872"},{"key":"10331_CR17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ejheart.2006.11.002","volume":"9","author":"H Patel","year":"2007","unstructured":"Patel H, Shafazand M, Schaufelberger M, Ekman I (2007) Reasons for seeking acute care in chronic heart failure. Eur J Heart Fail 9:702\u2013708. https:\/\/doi.org\/10.1016\/j.ejheart.2006.11.002","journal-title":"Eur J Heart Fail"},{"key":"10331_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1742-1241.1997.tb11438.x","volume":"51","author":"G Lip","year":"1997","unstructured":"Lip G, Zarifis J, Beevers DG (1997) Acute admissions with heart failure to a district general hospital serving a multiracial population. Int J Clin Pract 51:223\u2013227","journal-title":"Int J Clin Pract"},{"key":"10331_CR19","doi-asserted-by":"publisher","unstructured":"Jurgens CY, Lee CS, Aycock DM, Masterson Creber R, Denfeld QE, DeVon HA et al (2022) State of the science: the relevance of symptoms in cardiovascular disease and research: a scientific statement from the American Heart Association. Circulation 146. https:\/\/doi.org\/10.1161\/CIR.0000000000001089","DOI":"10.1161\/CIR.0000000000001089"},{"key":"10331_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11897-009-0039-z","volume":"6","author":"PB Adamson","year":"2009","unstructured":"Adamson PB (2009) Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Curr Heart Fail Rep 6:287\u2013292. https:\/\/doi.org\/10.1007\/s11897-009-0039-z","journal-title":"Curr Heart Fail Rep"},{"key":"10331_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10741-020-09963-7","volume":"26","author":"A Faragli","year":"2021","unstructured":"Faragli A, Abawi D, Quinn C, Cvetkovic M, Schlabs T, Tahirovic E et al (2021) The role of non-invasive devices for the telemonitoring of heart failure patients. Heart Fail Rev 26:1063\u20131080. https:\/\/doi.org\/10.1007\/s10741-020-09963-7","journal-title":"Heart Fail Rev"},{"key":"10331_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jacc.2010.03.049","volume":"56","author":"D Ferrante","year":"2010","unstructured":"Ferrante D, Varini S, Macchia A, Soifer S, Badra R, Nul D et al (2010) Long-term results after a telephone intervention in chronic heart failure. J Am Coll Cardiol 56:372\u2013378. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.049","journal-title":"J Am Coll Cardiol"},{"key":"10331_CR23","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.111.018473","volume":"123","author":"F Koehler","year":"2011","unstructured":"Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, B\u00f6hm M et al (2011) Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure. Circ 123:1873\u20131880. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.018473","journal-title":"Circ"},{"key":"10331_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamainternmed.2015.7712","volume":"176","author":"MK Ong","year":"2016","unstructured":"Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT et al (2016) Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure. JAMA Intern Med 176:310. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7712","journal-title":"JAMA Intern Med"},{"key":"10331_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.111.962969","volume":"5","author":"CE Angermann","year":"2012","unstructured":"Angermann CE, St\u00f6rk S, Gelbrich G, Faller H, Jahns R, Frantz S et al (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure. Circ Heart Fail 5:25\u201335. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.111.962969","journal-title":"Circ Heart Fail"},{"key":"10331_CR26","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/eurheartj\/ehx227","volume":"38","author":"JM Morgan","year":"2017","unstructured":"Morgan JM, Kitt S, Gill J, McComb JM, Ng GA, Raftery J et al (2017) Remote management of heart failure using implantable electronic devices. Eur Heart J 38:2352\u20132360. https:\/\/doi.org\/10.1093\/eurheartj\/ehx227","journal-title":"Eur Heart J"},{"key":"10331_CR27","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1056\/NEJMoa1010029","volume":"363","author":"SI Chaudhry","year":"2010","unstructured":"Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z et al (2010) Telemonitoring in patients with heart failure. N Engl J Med 363:2301\u20132309. https:\/\/doi.org\/10.1056\/NEJMoa1010029","journal-title":"N Engl J Med"},{"key":"10331_CR28","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/ejhf.1300","volume":"20","author":"F Koehler","year":"2018","unstructured":"Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Winkler S et al (2018) Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description. Eur J Heart Fail 20:1485\u20131493. https:\/\/doi.org\/10.1002\/ejhf.1300","journal-title":"Eur J Heart Fail"},{"key":"10331_CR29","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1161\/CIRCULATIONAHA.111.043042","volume":"124","author":"DJ van Veldhuisen","year":"2011","unstructured":"van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G et al (2011) Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circ 124:1719\u20131726. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.043042","journal-title":"Circ"},{"key":"10331_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jacc.2017.05.052","volume":"70","author":"WT Abraham","year":"2017","unstructured":"Abraham WT, Perl L (2017) Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol 70:389\u2013398. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.052","journal-title":"J Am Coll Cardiol"},{"key":"10331_CR31","doi-asserted-by":"publisher","unstructured":"Adamson PB, Abraham WT, Stevenson LW, Desai AS, Lindenfeld J, Bourge RC et al (2016) Pulmonary artery pressure\u2013guided heart failure management reduces 30-day readmissions. Circ Heart Fail 9. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002600","DOI":"10.1161\/CIRCHEARTFAILURE.115.002600"},{"key":"10331_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","volume":"387","author":"WT Abraham","year":"2016","unstructured":"Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB (2016) Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. The Lancet 387:453\u2013461. https:\/\/doi.org\/10.1016\/S0140-6736(15)00723-0","journal-title":"The Lancet"},{"key":"10331_CR33","doi-asserted-by":"publisher","unstructured":"Vasko MR (1985) Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 102:314. https:\/\/doi.org\/10.7326\/0003-4819-102-3-314","DOI":"10.7326\/0003-4819-102-3-314"},{"key":"10331_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0002-9343(98)00111-9","volume":"104","author":"SS Gottlieb","year":"1998","unstructured":"Gottlieb SS, Khatta M, Wentworth D, Roffman D, Fisher ML, Kramer WG (1998) The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure. Am J Med 104:533\u2013538. https:\/\/doi.org\/10.1016\/S0002-9343(98)00111-9","journal-title":"Am J Med"},{"key":"10331_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 24:4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333","journal-title":"Eur J Heart Fail"},{"key":"10331_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jama.2022.23924","volume":"329","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S et al (2023) Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure. JAMA 329:214. https:\/\/doi.org\/10.1001\/jama.2022.23924","journal-title":"JAMA"},{"key":"10331_CR37","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2215\/CJN.09630818","volume":"14","author":"DH Ellison","year":"2019","unstructured":"Ellison DH (2019) Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol 14:1248\u20131257. https:\/\/doi.org\/10.2215\/CJN.09630818","journal-title":"Clin J Am Soc Nephrol"},{"key":"10331_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jpainsymman.2016.05.004","volume":"52","author":"L Carone","year":"2016","unstructured":"Carone L, Oxberry SG, Twycross R, Charlesworth S, Mihalyo M, Wilcock A (2016) Furosemide. J Pain Symptom Manage 52:144\u2013150. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.05.004","journal-title":"J Pain Symptom Manage"},{"key":"10331_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola V-P, Mebazaa A, Brunner-La Rocca H-P, Martens P et al (2019) The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:137\u2013155. https:\/\/doi.org\/10.1002\/ejhf.1369","journal-title":"Eur J Heart Fail"},{"key":"10331_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/HHF.0000000000000006","volume":"8","author":"NM Albert","year":"2015","unstructured":"Albert NM, Barnason S, Deswal A, Hernandez A, Kociol R, Lee E et al (2015) Transitions of care in heart failure. Circ Heart Fail 8:384\u2013409. https:\/\/doi.org\/10.1161\/HHF.0000000000000006","journal-title":"Circ Heart Fail"},{"key":"10331_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejheart.2008.01.003","volume":"10","author":"M Ryder","year":"2008","unstructured":"Ryder M, Murphy NF, McCaffrey D, O\u2019Loughlin C, Ledwidge M, McDonald K (2008) Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail 10:267\u2013272. https:\/\/doi.org\/10.1016\/j.ejheart.2008.01.003","journal-title":"Eur J Heart Fail"},{"key":"10331_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.amjmed.2014.11.028","volume":"128","author":"S Makadia","year":"2015","unstructured":"Makadia S, Simmons T, Augustine S, Kovell L, Harris C, Chibungu A et al (2015) The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure. Am J Med 128:527\u2013531. https:\/\/doi.org\/10.1016\/j.amjmed.2014.11.028","journal-title":"Am J Med"},{"key":"10331_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2015.06.017","volume":"4","author":"LF Buckley","year":"2016","unstructured":"Buckley LF, Carter DM, Matta L, Cheng JW, Stevens C, Belenkiy RM et al (2016) Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. JACC Heart Fail 4:1\u20138. https:\/\/doi.org\/10.1016\/j.jchf.2015.06.017","journal-title":"JACC Heart Fail"},{"key":"10331_CR44","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ehf2.12677","volume":"7","author":"E Wierda","year":"2020","unstructured":"Wierda E, Dickhoff C, Handoko ML, Oosterom L, Kok WE, Rover Y et al (2020) Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature. ESC Heart Fail 7:892\u2013902. https:\/\/doi.org\/10.1002\/ehf2.12677","journal-title":"ESC Heart Fail"},{"key":"10331_CR45","doi-asserted-by":"publisher","unstructured":"Dahiya G, Bensimhon D, Goodwin MM, Mohr JF, Alexy T (2022) From oral to subcutaneous furosemide: the road to novel opportunities to manage congestion.\u00a0Struct Heart\u00a06:100076. https:\/\/doi.org\/10.1016\/j.shj.2022.100076","DOI":"10.1016\/j.shj.2022.100076"},{"key":"10331_CR46","doi-asserted-by":"publisher","first-page":"E232","DOI":"10.1503\/cmaj.110372","volume":"184","author":"C Quach","year":"2012","unstructured":"Quach C, McArthur M, McGeer A, Li L, Simor A, Dionne M et al (2012) Risk of infection following a visit to the emergency department: a cohort study. Can Med Assoc J 184:E232\u2013E239. https:\/\/doi.org\/10.1503\/cmaj.110372","journal-title":"Can Med Assoc J"},{"key":"10331_CR47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41467-022-28291-y","volume":"13","author":"BB Lindsey","year":"2022","unstructured":"Lindsey BB, Villabona-Arenas ChJ, Campbell F, Keeley AJ, Parker MD, Shah DR et al (2022) Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves. Nat Commun 13:671. https:\/\/doi.org\/10.1038\/s41467-022-28291-y","journal-title":"Nat Commun"},{"key":"10331_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1345\/aph.1D332","volume":"38","author":"AK Verma","year":"2004","unstructured":"Verma AK, da Silva JH, Kuhl DR (2004) Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study. Ann Pharmacother 38:544\u2013549. https:\/\/doi.org\/10.1345\/aph.1D332","journal-title":"Ann Pharmacother"},{"key":"10331_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/0269216311399490","volume":"25","author":"H Zacharias","year":"2011","unstructured":"Zacharias H, Raw J, Nunn A, Parsons S, Johnson M (2011) Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure? Palliat Med 25:658\u2013663. https:\/\/doi.org\/10.1177\/0269216311399490","journal-title":"Palliat Med"},{"key":"10331_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bmjspcare-2012-000296","volume":"3","author":"J Galindo-Oca\u00f1a","year":"2013","unstructured":"Galindo-Oca\u00f1a J, Romero-Mena J, Castillo-Ferrando JR, Aguilera-Gonz\u00e1lez C, Bernabeu-Wittel M, Ollero-Baturone M (2013) Subcutaneous furosemide as palliative treatment in patients with advanced and terminal-phase heart failure. BMJ Support Palliat Care 3:7\u20139. https:\/\/doi.org\/10.1136\/bmjspcare-2012-000296","journal-title":"BMJ Support Palliat Care"},{"key":"10331_CR51","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nefro.2017.09.001","volume":"38","author":"M Picazo S\u00e1nchez","year":"2018","unstructured":"Picazo S\u00e1nchez M, Castillo Lorenzo MN, Cuxart P\u00e9rez M, Sans LR (2018) Uso paliativo de la furosemida en infusi\u00f3n continua subcut\u00e1nea en un paciente trasplantado renal con fallo card\u00edaco. Nefrologia 38:438\u2013439. https:\/\/doi.org\/10.1016\/j.nefro.2017.09.001","journal-title":"Nefrologia"},{"key":"10331_CR52","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.rec.2013.06.008","volume":"66","author":"E Zatarain-Nicol\u00e1s","year":"2013","unstructured":"Zatarain-Nicol\u00e1s E, L\u00f3pez-D\u00edaz J, de la Fuente-Gal\u00e1n L, Garc\u00eda-Pardo H, Recio-Platero A, San Rom\u00e1n-Calvar JA (2013) Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 66:1002\u20131004. https:\/\/doi.org\/10.1016\/j.rec.2013.06.008","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"10331_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jacbts.2017.10.001","volume":"3","author":"DA Sica","year":"2018","unstructured":"Sica DA, Muntendam P, Myers RL, ter Maaten JM, Sale ME, de Boer RA et al (2018) Subcutaneous furosemide in heart failure. JACC Basic Transl Sci 3:25\u201334. https:\/\/doi.org\/10.1016\/j.jacbts.2017.10.001","journal-title":"JACC Basic Transl Sci"},{"key":"10331_CR54","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.cardfail.2019.07.213","volume":"25","author":"GM Felker","year":"2019","unstructured":"Felker GM, Redfield MM, Mentz RJ, Dunlap ME, Lewis GD, Smith AL et al (2019) Subcutaneous furosemide in the treatment of patients with decompensated heart failure: data from the sub-Q pilot studies. J Card Fail 25:S75. https:\/\/doi.org\/10.1016\/j.cardfail.2019.07.213","journal-title":"J Card Fail"},{"key":"10331_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchf.2017.10.001","volume":"6","author":"NA Gilotra","year":"2018","unstructured":"Gilotra NA, Princewill O, Marino B, Okwuosa IS, Chasler J, Almansa J et al (2018) Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure. JACC Heart Fail 6:65\u201370. https:\/\/doi.org\/10.1016\/j.jchf.2017.10.001","journal-title":"JACC Heart Fail"},{"key":"10331_CR56","unstructured":"Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure (FREEDOM-HF) https:\/\/beta.clinicaltrials.gov\/study\/NCT03458325?tab=results. Published November 7, 2022. Accessed 29 Jan 2023"},{"key":"10331_CR57","unstructured":"Avoiding Treatment in Hospital with FUROSCIX to Manage Congestion in Heart Failure (AT HOME-HF) \u2013 a pilot study. https:\/\/scpharmaceuticalsinc.gcs-web.com\/news-releases\/news-release-details\/scpharmaceuticals-announces-data-presentations-heart-failure. Published September 30, 2022. Accessed 29 Jan 2023"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10331-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:15:48Z","timestamp":1697184948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10331-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["10331"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10331-4","relation":{},"ISSN":["1573-7322"],"issn-type":[{"type":"electronic","value":"1573-7322"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"4 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"DB and TA serve on the speakers\u2019 bureau and as consultants for scPharmaceuticals. TA is also on the speakers\u2019 bureau for Abbott, Inc. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}